This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
BLIRT Past Earnings Performance
Past criteria checks 2/6
Key information
75.1%
Earnings growth rate
76.4%
EPS growth rate
| Biotechs Industry Growth | 56.3% |
| Revenue growth rate | 55.5% |
| Return on equity | 28.5% |
| Net Margin | 19.0% |
| Next Earnings Update | 11 Aug 2022 |
Recent past performance updates
Recent updates
Market Cool On BLIRT S.A.'s (WSE:BLR) Earnings Pushing Shares 26% Lower
Oct 02
BLIRT S.A. (WSE:BLR) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Oct 02BLIRT's (WSE:BLR) Earnings Are Of Questionable Quality
May 19Will Weakness in BLIRT S.A.'s (WSE:BLR) Stock Prove Temporary Given Strong Fundamentals?
Jan 14
With EPS Growth And More, BLIRT (WSE:BLR) Is Interesting
Dec 09Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow BLIRT makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 40 | 8 | 19 | 0 |
| 30 Sep 21 | 59 | 19 | 24 | 0 |
| 30 Jun 21 | 67 | 23 | 27 | 0 |
| 31 Mar 21 | 70 | 26 | 25 | 0 |
| 31 Dec 20 | 65 | 22 | 22 | 0 |
| 30 Sep 20 | 36 | 9 | 13 | 0 |
| 30 Jun 20 | 23 | 6 | 9 | 0 |
| 31 Mar 20 | 14 | 0 | 7 | 0 |
| 31 Dec 19 | 10 | -1 | 7 | 0 |
| 30 Sep 19 | 11 | 1 | 7 | 0 |
| 30 Jun 19 | 10 | 1 | 6 | 0 |
| 31 Mar 19 | 9 | -1 | 6 | 0 |
| 31 Dec 18 | 8 | -2 | 6 | 0 |
| 30 Sep 18 | 6 | -3 | 6 | 0 |
| 30 Jun 18 | 6 | -4 | 7 | 0 |
| 31 Mar 18 | 6 | -4 | 7 | 0 |
| 31 Dec 17 | 6 | -3 | 7 | 0 |
| 30 Sep 17 | 5 | -4 | 7 | 0 |
| 30 Jun 17 | 5 | -3 | 6 | 0 |
| 31 Mar 17 | 5 | -4 | 7 | 0 |
| 31 Dec 16 | 5 | -4 | 6 | 0 |
| 30 Sep 16 | 7 | -2 | 7 | 0 |
| 30 Jun 16 | 7 | -2 | 7 | 0 |
| 31 Mar 16 | 7 | -2 | 7 | 0 |
| 31 Dec 15 | 6 | -2 | 7 | 0 |
| 30 Sep 15 | 4 | -3 | 7 | 0 |
Quality Earnings: BLR has a high level of non-cash earnings.
Growing Profit Margin: BLR's current net profit margins (19%) are lower than last year (34.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BLR has become profitable over the past 5 years, growing earnings by 75.1% per year.
Accelerating Growth: BLR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: BLR had negative earnings growth (-66%) over the past year, making it difficult to compare to the Biotechs industry average (5.1%).
Return on Equity
High ROE: BLR's Return on Equity (28.5%) is considered high.